The global latanoprost market was valued at $1.3 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.
Report Code : A324461 | Pages : 240 | Category : Life Sciences
The erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.
Report Code : A00001 | Pages : 165 | Category : Life Sciences
The global protein therapeutics market size was valued at $283.64 Billion in 2020, and is estimated to reach $566.66 Billion by 2030, growing at a CAGR of 7.1% ...
Report Code : A00002 | Pages : 211 | Category : Life Sciences
Secure packaging is one of the essential techniques to avoid counterfeiting. Anti counterfeit packaging is defined as the process of assigning secure packaging to the product in order ...
Report Code : A00029 | Pages : 341 | Category : Life Sciences
The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A00042 | Pages : 250 | Category : Life Sciences
The global global therapeutic vaccines market was valued at $26.7 billion in 2023, and is projected to reach $135.7 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.
Report Code : A00074 | Pages : 300 | Category : Life Sciences
The global point of care diagnostics market was valued at $29,478.63 million in 2020 and is projected to reach $55,275.73 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A00080 | Pages : 215 | Category : Life Sciences
The global biosimilars market was valued at $15.9 billion in 2021, and is projected to reach $143.6 billion by 2031, growing at a CAGR of 24.7% from 2022 to 2031.
Report Code : A00573 | Pages : 242 | Category : Life Sciences
The global Asthma and COPD Drugs Market Size was valued at $32988.7 million in 2020 and is projected to reach $52049.54 million by 2030, registering a CAGR of 4.64% from 2021 to 2030.
Report Code : A00221 | Pages : 120 | Category : Life Sciences
The global ovarian cancer drugs market was valued at $2.3 billion in 2021, and is projected to reach $5.1 billion by 2031, growing at a CAGR of 8.4% from 2022 to 2031.
Report Code : A00273 | Pages : 189 | Category : Life Sciences
